The Predictive Value of Longitudinal Monitoring of Mutated EGFR in Plasma of Advanced NSCLC Patients on First-Line EGFR-TKIs

被引：0

作者：

Szpechcinski, A. ^{[1
]}

Bryl, M. ^{[2
]}

Wojda, E. ^{[1
]}

Czyzewicz, G. ^{[3
]}

Swiniuch, D. ^{[4
]}

Szwiec, M. ^{[5
]}

Ramlau, R. ^{[4
]}

Sliwinski, P. ^{[1
]}

Barinow-Wojewodzki, A. ^{[2
]}

Chorostowska-Wynimko, J. ^{[1
]}

机构：

[1] Inst TB & Lung Dis, Warsaw, Poland

[2] EJ Zeyland Wielkopolska Ctr Pulmonol & Thorac Sur, Poznan, Poland

[3] John Paul II Specialist Hosp, Krakow, Poland

[4] Med Univ Poznan, Poznan, Poland

[5] Univ Hosp Zielona Gora, Zielona Gora, Poland

来源：

JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 09期

关键词：

non-small cell lung cancer; EGFR mutations; liquid biopsy;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EP08.02-07

引用

页码：S434 / S435

页数：2

共 50 条

[21] Efficacy of EGFR-TKIs Compared with Chemotherapy as First-Line Therapy in Patients with EGFR Rare Mutation Advanced Lung Adenocarcinoma
Wang, H.
Li, H.
Zhang, M.
Zhang, G.
Zhang, X.
Ma, Z.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S985 - S985
[22] Surgical Resection Improves the Survival of NSCLC Patients with Pleural Metastasis Treated with First-Line EGFR-TKIs
Zhang, B.
Xiao, Q.
JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1051 - S1051
[23] EGFR-TKIs or EGFR-TKIs combination treatments for untreated advanced EGFR-mutated NSCLC: a network meta-analysis (vol 24, 1390, 2024)
Liu, Ao
Wang, Xiaoming
Wang, Lian
Zhuang, Han
Xiong, Liubo
Gan, Xiao
Wang, Qian
Tao, Guanyu
BMC CANCER, 2025, 25 (01)
[24] Advanced NSCLC Patients at the Extremes of Age in the Era of EGFR-TKIs
Chen, Yu-Mu
Lai, Chien-Hao
Chang, Huang-Chih
Chao, Tung-Ying
Tseng, Chia-Cheng
Fang, Wen-Feng
Chung, Yu-Hsiu
Wang, Yi-Hsi
Su, Mao-Chang
Huang, Kuo-Tung
Wang, Chin-Chou
Lin, Meng-Chih
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1445 - S1445
[25] Antacid and de novo brain metastases in EGFR-mutant NSCLC patients treated with first-line, first-generation EGFR-TKIs
Chen, Y-M.
Lin, M-C.
Lai, C-H.
Fang, W-F.
Chang, H-C.
Wang, C-C.
Tseng, C-C.
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S132 - S132
[26] Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients
Xiong, Liwen
Cui, Shaohua
Ding, Jingyan
Sun, Yun
Zhang, Longfu
Zhao, Yizhuo
Gu, Aiqin
Chu, Tianqing
Wang, Huimin
Zhong, Hua
Ye, Xin
Gu, Yi
Zhang, Xin
Hu, Min
Jiang, Liyan
ONCOTARGET, 2017, 8 (38) : 63846 - 63856
[27] Plasma EGFR mutation abundance affects clinical response to first-line EGFR-TKIs in patients with advanced non-small cell lung cancer
Wang, Xiaohong
Liu, Yonggang
Meng, Zhiying
Wu, Yun
Wang, Shubin
Jin, Gaowa
Qin, Yingchun
Wang, Fengyun
Wang, Jing
Zhou, Haifei
Su, Xiaoxing
Fu, Xiuhua
Wang, Xiaolan
Shi, Xiaoyu
Wen, Zhenping
Jia, Xiaoqiong
Qin, Qiong
Gao, Yongqiang
Guo, Weidong
Lu, Shun
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
[28] A Retrospective Single-Center Analysis of Patients with Atypical EGFRm NSCLC Treated with First-Line EGFR-TKIs
Hong, L.
Du, R.
Lee, J. Jack
Heymach, J. V.
Le, X.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E28 - E29
[29] Dynamic Evaluation of Circulating miRNA Profile in EGFR-Mutated NSCLC Patients Treated with EGFR-TKIs
Leonetti, Alessandro
Capula, Mjriam
Minari, Roberta
Mazzaschi, Giulia
Gregori, Alessandro
El Hassouni, Btissame
Papini, Filippo
Bordi, Paola
Verze, Michela
Avan, Amir
Tiseo, Marcello
Giovannetti, Elisa
CELLS, 2021, 10 (06)
[30] Combination of EGFR-TKIs with Chemotherapy versus EGFR-TKIs alone in EGFR-Mutant Advanced NSCLC with Concomitant Genetic Alterations
Feng, W.
Gu, W.
Zhang, H.
Lu, Y.
Gu, W.
Li, M.
Yang, S.
Zhang, J.
Ye, Z.
Lin, Q.
Liang, Y.
Chen, H.
Cheng, Y.
Yao, M.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S622 - S622

← 1 2 3 4 5 →